X
This biotech company develops advanced blood tests for the early detection and monitoring of cancer. They utilize multiomics and AI methodologies to identify cancer-associated biomarkers in patient samples. The goal is to provide highly accurate, accessible diagnostics to improve patient outcomes and reduce cancer mortality.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Xemperia develops advanced blood tests for the early detection and monitoring of cancer using multiomics and AI methodologies. The company leverages biomarker discovery expertise to create highly accurate, scalable diagnostic solutions for various cancer types. Their goal is to enhance patient outcomes by providing life-saving information across all stages of cancer disease.